2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine structure
|
Common Name | 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine | ||
|---|---|---|---|---|
| CAS Number | 2072145-79-8 | Molecular Weight | 600.57 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C32H28N2O10 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine |
|---|
| Description | 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C32H28N2O10 |
|---|---|
| Molecular Weight | 600.57 |
| InChIKey | NTJIHUGVIKTSOW-XCOQKUFESA-N |
| SMILES | COc1cn(C2OC(COC(=O)c3ccccc3)C(OC(=O)c3ccccc3)C2(C)OC(=O)c2ccccc2)c(=O)[nH]c1=O |